Early-stage biotech developing a gene therapy for wet AMD.
Industry: Health Care
First Day Return: +64.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/30/2014 |
Offer Price | $17.00 |
Price Range $16.00 - $17.00 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $102 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/30/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $102 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Menlo Park, CA, United States |
Founded | 2006 |
Employees at IPO | 14 |
Website www.avalanchebiotech.com |